Davis Polk & Wardwell and Zhong Lun Law Firm advised Chinese biopharmaceutical company Antengene Corporation on its $335 million IPO in Hong Kong, with Herbert Smith Freehills and Commerce & Finance Law Offices advising the joint sponsors and the underwriters.

Antengene is a clinical-stage Asia-Pacific biopharmaceutical company offering R&D capabilities and oncology therapies.

The listing is the latest by a Chinese biopharmaceutical company in Hong Kong, which has seen a flurry of such IPOs. Recent other issuers include Simcere Pharmaceutical Group, JHBP (CY) Holdings and Everest Medicines.

The Herbert Smith Freehills team was led by Matt Emsley and Stanley Xie.

 

To contact the editorial team, please email ALBEditor@thomsonreuters.com. 

Related Articles

Deals

SAM, Luthra, Simmons guide planned $360 mln India renewable energy IPO

by Asian Legal Business《亚洲法律杂志》 |

Shardul Amarchand Mangaldas & Co is advising Indian renewable energy firm ACME Solar Holdings on its planned 30-billion-rupee ($360 million) initial public offering, with Luthra & Luthra Law Offices and Simmons & Simmons representing the book-running lead managers.

Deals

Paul Hastings advises Korean gaming firm on $315 mln IPO

by Asian Legal Business《亚洲法律杂志》 |

U.S. law firm Paul Hastings has advised Tencent-backed South Korean gaming company Shift Up on its 435-billion-won ($315 million) initial public offering on the Korea Exchange.

Deals

Latham, Links advise on Malaysia's largest IPO in 2 years

by Asian Legal Business《亚洲法律杂志》 |

Latham & Watkins and Mah-Kamariyah & Philip Koh have advised Malaysian palm oil company Johor Plantations Group on its 735-million-ringgit ($157 million) initial public offering, the country's biggest in more than two years.